Cannabis Kills Some Oral Bacteria but Promotes Others, Potentially Worsening Gum Disease

Multiple oral bacteria were sensitive to physiological CBD concentrations, including A. actinomycetemcomitans, F. nucleatum, P. gingivalis, S. mutans, and T. forsythia. However, other pathobionts were resistant even at superphysiological CBD concentrations, including oral Treponema species, C. gracilis, and V. parvula. This selective killing may create microbial dysbiosis favoring resistant pathogens.

Panel of oral bacteria tested for CBD susceptibility at physiological and superphysiological concentrations. Results informed by initial in vivo microbiome analysis of marijuana users and non-users with periodontitis. Antimicrobial peptoids were screened for activity against CBD-resistant bacteria.

Cannabis users have higher rates of periodontal disease, and the mechanism has been unclear. This study provides a compelling explanation: cannabis selectively kills some oral bacteria while sparing others, creating an imbalanced oral microbiome that favors disease-causing species.

This is the first mechanistic explanation for cannabis-associated periodontitis that accounts for both the antibacterial properties of cannabinoids and the paradox of worsened oral disease. It also points toward a potential solution: antimicrobial peptoids that target the resistant bacteria could be developed as adjunctive treatments.

In vitro susceptibility testing may not reflect conditions in the oral cavity. CBD concentrations achievable in saliva depend on consumption method. Microbiome analysis was preliminary and from a small sample. Peptoid treatments are experimental and not yet tested in vivo.